Hematology

The CGTLive™ Hematology specialty topic page houses the most up-to-date clinical news coverage in the field of hematology gene and cell therapy. It also includes video interviews with key opinion leaders in the field of hematology/oncology about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings related to the development of cell therapies, gene therapies, and engineered and regenerative medicines for various blood disorders.

Latest News

Immix and Nexcella Make Progress in US Trial for Light Chain Amyloidosis CAR-T NXC-201
Immix and Nexcella Make Progress in US Trial for Light Chain Amyloidosis CAR-T NXC-201

October 6th 2024

NEXICART-2 has moved on to its expansion cohort after completing dosing of patients in its initial cohort.

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – October 4, 2024

October 4th 2024

Data Roundup: September 2024 Features Updates in Ophthalmology Gene Therapy, CAR-T for Lymphoma, and More
Data Roundup: September 2024 Features Updates in Ophthalmology Gene Therapy, CAR-T for Lymphoma, and More

October 4th 2024

First Patient Dosed Achieves Complete Response in Estrella Immunopharma’s Trial for CD19-Targeted T-cell Therapy EB103 in B-Cell Lymphomas
First Patient Dosed Achieves Complete Response in Estrella Immunopharma’s Trial for CD19-Targeted T-cell Therapy EB103 in B-Cell Lymphomas

October 3rd 2024

Around the Helix: Cell and Gene Therapy Company Updates – October 2, 2024
Around the Helix: Cell and Gene Therapy Company Updates – October 2, 2024

October 2nd 2024

Latest CME Events & Activities

Crucial Conversations in R/R Multiple Myeloma: Nursing Strategies to Optimize Patient Communication and Improve Outcomes

View More

Oncology Briefings™: Coordinating the Long-Term Management of Patients With Multiple Myeloma Between Primary Care and Oncology Practices

View More

GlobaOncology Town Hall™: Primary Investigators Present Key Abstracts in the Management of B-Cell Lymphomas with BTK Inhibitors

View More

Community Practice Connections™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in AML

View More

Community Practice Connections: 7th Annual School of Nursing Oncology™

View More

6th Annual Precision Medicine Symposium: An Illustrated Tumor Board

October 18-19, 2024

Register Now!

Community Oncology Connections™: Selecting and Sequencing Therapy for Patients With DLBCL in an Era of Expanding Options

View More

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

Oncology Consultations®: Community and Academic Perspectives on PNH Management – How Do You Do It?

View More

Community Oncology Connections™: Overcoming Clinical Challenges and Embracing New Opportunities in the Management of Multiple Myeloma

View More

Cases and Conversations™: Applying Guidelines to Practice for the Management of Paroxysmal Nocturnal Hemoglobinuria

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Oncology Briefings™: Selecting Therapy for Patients with Heavily Pretreated Myeloma Based on Patient and Disease-Specific Factors

View More

Oncology Briefings™: Case Discussions in Smoldering Myeloma—To Treat or Not to Treat?

View More

Medical Crossfire®: How Has the Nurse’s Role Evolved in the Management of Pediatric Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas?

View More

Community Practice Connections™: How Can We Optimize the Real World Application of BCMA-Targeted Therapies for Our Patients with R/R Multiple Myeloma?

View More

Annual Hematology Meeting: Preceding the 66th ASH Annual Meeting and Exposition

December 6, 2024

Register Now!

Oncology Town Hall™: Primary Investigators Present Key Abstracts in CLL from San Diego

View More

Understanding the Recent Developments in Myelodysplastic Syndromes (MDS)

View More

Focusing on Key Updates on the Outlook of Acute Lymphocytic Leukemia (ALL) Management

View More

Experts Address the Hottest Topics in AML: Considerations on FLT3, IDH1/2, TP53, Maintenance, Novel Combinations and Beyond!

View More

Medical Crossfire®: Novel BTKi Strategies Transforming Aggressive and Indolent B-Cell Malignancies

View More

Medical Crossfire®: Bridging Expert Guidance and Evidence-Based Recommendations in the Treatment of AYA and Adult ALL

View More

Translating New Evidence into Treatment Algorithms from Frontline to R/R Multiple Myeloma: How the Experts Think & Treat

View More

Putting Your Stamp on the Next Generation of Care in CML — Improving Outcomes from Frontline to R/R Treatment Settings

View More

Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?

View More

How Do We Treat GVHD Today…And Tomorrow? Treatment Algorithms for Key Decision Points in Prophylaxis Care, Acute, and Chronic Disease

View More

Real-World Applications of Asparaginase Formulations in ALL and LBL From Pediatric/AYA to Adult Treatment: Maximizing Clinical Benefits Through Multidisciplinary Care

View More

The Latest Advancements in the Treatment of Chronic Myeloid Leukemia (CML)

View More

The Effect of Recent Updates on the Outlook of Acute Myeloid Leukemia (AML) Management

View More

© 2024 MJH Life Sciences

All rights reserved.